cash flow reconciliationreview2024-09-30
Operating, investing and financing flows differ from the reported change in cash by 462000000, beyond tolerance 2310000.00.
Revenue
$2.22B
Fiscal year ended 2025-09-30Operating income
$96.60M
Fiscal year ended 2025-09-30Free cash flow
Unavailable
Fiscal year ended 2025-09-30EDGEWELL PERSONAL CARE Co (EPC) reported revenue of $2.22B and net income of $25.40M for the fiscal year ended 2025-09-30. This page shows 9 annual periods of income statement, balance sheet and cash flow figures normalized from EDGEWELL PERSONAL CARE Co’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Perfumes, Cosmetics & Other Toilet Preparations.
Income
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.22B | $2.25B | $2.25B | $2.17B | $2.09B | $1.95B | $2.14B | $2.23B | $2.30B |
| Cost of revenue | $1.30B | $1.30B | $1.31B | $1.29B | $1.14B | $1.07B | $1.17B | $1.20B | $1.17B |
| Gross profit | $924.90M | $955.70M | $940.80M | $880.50M | $951.20M | $880.90M | $966.60M | $1.03B | $1.13B |
| Operating income | $96.60M | $199.30M | $227.00M | $182.30M | $239.90M | $176.00M | $243.80M | Unavailable | Unavailable |
| Net income | $25.40M | $98.60M | $114.70M | $99.50M | $117.80M | $67.60M | -$372.20M | $103.30M | $5.70M |
| Research & development | $57.60M | $58.40M | $58.50M | $55.50M | $57.80M | $55.30M | $53.50M | $61.10M | $67.60M |
| Weighted-average diluted shares | shares 47.60M | shares 50.10M | shares 51.80M | shares 53.60M | shares 55.20M | shares 54.60M | shares 54.10M | shares 54.50M | shares 57.50M |
| Pretax income | $23.60M | $120.90M | $147.70M | $124.10M | $147.10M | $87.30M | -$390.30M | $163.80M | -$52.90M |
| Income tax expense | -$1.80M | $22.30M | $33.00M | $24.60M | $29.30M | $19.70M | -$18.10M | $60.50M | -$58.60M |
| Diluted EPS | $0.53 | $1.97 | $2.21 | $1.85 | $2.13 | $1.24 | $-6.88 | $1.90 | $0.10 |
| Selling, general & administrative | $425.00M | $430.10M | $409.60M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | $209.10M | $216.40M | $188.70M | $479.20M | $364.70M | $341.60M | $266.40M | $502.90M |
| Total assets | $3.76B | $3.73B | $3.74B | $3.71B | $3.67B | $3.54B | $3.42B | $3.95B | $4.19B |
| Current assets | $995.50M | $936.00M | $962.40M | $942.20M | $1.14B | $983.60M | $1.04B | $951.20M | $1.19B |
| Total liabilities | $2.20B | $2.15B | $2.20B | $2.25B | $2.09B | $2.11B | $2.12B | $2.21B | $2.45B |
| Current liabilities | $565.50M | $563.60M | $523.40M | $539.50M | $536.80M | $510.50M | $659.60M | $717.00M | $524.40M |
| Total equity incl. NCI | $1.55B | $1.58B | $1.54B | $1.47B | $1.59B | $1.44B | $1.30B | $1.74B | $1.74B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $433.80M | $477.30M | $492.40M | $449.30M | $345.70M | $314.10M | $357.20M | $329.50M | $333.50M |
| Accounts receivable | $137.80M | $109.40M | $106.20M | $136.90M | $150.70M | $158.80M | $205.60M | $226.50M | $224.10M |
| Goodwill | $1.14B | $1.34B | $1.33B | $1.32B | $1.16B | $1.16B | $1.03B | $1.45B | $1.45B |
| Long-term debt | $1.38B | $1.28B | $1.36B | $1.39B | $1.23B | $1.24B | $1.10B | $1.10B | $1.53B |
| Accounts payable | $219.70M | $219.30M | $194.40M | $228.80M | $209.50M | $181.90M | $222.80M | $238.40M | $223.60M |
Cash flow
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $118.40M | -$231.00M | -$216.10M | $102.00M | $229.00M | $232.60M | $190.60M | $259.40M | $313.60M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$72.90M | -$62.40M | -$50.50M | -$355.40M | -$48.70M | -$196.40M | -$45.50M | -$118.80M | -$84.60M |
| Financing cash flow | -$30.00M | -$179.40M | -$146.50M | -$17.60M | -$65.40M | -$18.70M | -$63.80M | -$379.60M | -$478.00M |
| Net change in cash | $16.60M | -$7.30M | $27.70M | -$290.50M | $114.50M | $23.10M | $75.20M | -$236.50M | -$236.00M |
| Stock-based compensation | $24.50M | $26.50M | $27.50M | $23.80M | $27.30M | $19.20M | $17.80M | $17.00M | $22.20M |
| Common dividends paid | $29.30M | $30.70M | $31.50M | $32.60M | $25.60M | $0 | $0 | Unavailable | $0 |
| Common share repurchases | $90.20M | $58.50M | $75.20M | $125.30M | $9.20M | $0 | $0 | $124.40M | $165.40M |
| Depreciation & amortization | $88.80M | $88.00M | $91.40M | $89.90M | $87.10M | $88.80M | $93.80M | $97.60M | $94.40M |
Derived
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 41.6% | 42.4% | 41.8% | 40.5% | 45.6% | 45.2% | 45.1% | 46.2% | 49.0% |
| Operating margin | 4.3% | 8.8% | 10.1% | 8.4% | 11.5% | 9.0% | 11.4% | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.1% | 1.2% | 1.2% | 1.1% | 1.3% | 1.0% | 0.8% | 0.8% | 1.0% |
| Current ratio | 1.76x | 1.66x | 1.84x | 1.75x | 2.12x | 1.93x | 1.58x | 1.33x | 2.26x |
| Revenue YoY growth | -1.3% | 0.1% | 3.7% | 4.0% | 7.1% | -8.9% | -4.2% | -2.8% | Unavailable |
| Net margin | 1.1% | 4.4% | 5.1% | 4.6% | 5.6% | 3.5% | -17.4% | 4.6% | 0.2% |
| R&D / revenue | 2.6% | 2.6% | 2.6% | 2.6% | 2.8% | 2.8% | 2.5% | 2.7% | 2.9% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.89x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | -7.6% | 18.4% | 22.3% | 19.8% | 19.9% | 22.6% | Unavailable | 36.9% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EPC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-09View SEC filing
10-K · Filed 2025-11-18View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2023-09-30
Operating, investing and financing flows differ from the reported change in cash by 432200000, beyond tolerance 2161000.00.
balance equationreview2021-09-30
Difference 6500000 exceeds tolerance 3674600.000. Presentation or filing-vintage differences need review.
balance equationreview2020-09-30
Difference 5700000 exceeds tolerance 3540900.000. Presentation or filing-vintage differences need review.